Pure Global

Vaginal versus cesarean delivery for fetal macrosomia - Trial PACTR201203000370221

Access comprehensive clinical trial information for PACTR201203000370221 through Pure Global AI's free database. This Not Applicable trial is sponsored by Ain Shams University and is currently Recruiting. The study focuses on Pregnancy and Childbirth; Surgery; Other.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR201203000370221
Not Applicable
Recruiting
Trial Details
Pan Africa Clinical Trials Registry โ€ข PACTR201203000370221
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Vaginal versus cesarean delivery for fetal macrosomia

Study Focus

Sponsor & Location

Ain Shams University

Pan Africa

Timeline & Enrollment

Not Applicable

Jul 01, 2010

Jan 01, 1900

Summary

Fetal macrosomia is defined as birthweight above 4000 or 4500, irrespective of gestational age. Although debate concerning how best to manage suspected macrosomia continues, the question still remains largely unanswered. The study was planned to test this null hypothesis there is no difference between Cesarean delivery and vaginal delivery of suspected macrosomia in preventing maternal and neonatal adverse outcomes""

ICD-10 Classifications

Other complications of obstetric surgery and procedures
Pregnancy, childbirth and the puerperium
Fetus and newborn affected by surgical procedure on mother
Other specified complications of labour and delivery
Personal history of complications of pregnancy, childbirth and the puerperium

Data Source

Pan Africa Clinical Trials Registry

PACTR201203000370221

Non-Device Trial